Skip to main content
Equibles

UBS Group AG

Position in AVBP — ArriVent BioPharma, Inc.

CIK 1610520 ZURICH, V8
Back to AVBP Full portfolio

Position in AVBP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$15,236,755
+$4,018,668 QoQ
Shares Held
438,594
-9.8% QoQ
Ownership
0.890%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 158 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,681,375 across 562 Biotechnology names. AVBP ranks #93 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in AVBP

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,236,755 438,594
2026-03-31 $11,218,087 486,263
2025-12-31 $9,072,509 450,920
2025-09-30 $9,180,738 497,601
2025-06-30 $1,885,020 86,588
2025-03-31 $3,738,400 202,185
2024-12-31 $1,936,541 72,693
2024-09-30 $437,945 18,636
2024-06-30 $222,320 11,985
2024-03-31 $176,724 9,895